Medical Equipment

Autotransfusion Devices Industry Forecast to Hit $1.67 Billion by 2029 With a Strong 7.2% CAGR

November 17, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Autotransfusion Devices Market Size During 2025–2029?

The valuation of the autotransfusion devices market has experienced consistent expansion throughout the past several years, with projections indicating a rise from the current $1.21 billion in 2024 to $1.26 billion by 2025, reflecting a compound annual growth rate (CAGR) of 4.4 percent. This upward trajectory observed during the historical timeframe is fundamentally driven by a combination of factors, including a higher incidence of surgical interventions, the increasing prevalence of cardiovascular ailments, a greater volume of orthopedic operations and joint replacement surgeries being performed, enhanced attention toward ensuring patient well-being, and ongoing initiatives aimed at decreasing the overall expense associated with blood transfusions.

Anticipation is building for substantial expansion within the sphere of autotransfusion devices over the forthcoming years, with projections indicating the market valuation will reach $1.67 billion by 2029, propelled by a compound annual growth rate (CAGR) of 7.2%. This upward trajectory throughout the forecast window is fundamentally linked to several key factors: the increasing number of elderly individuals requiring medical intervention, the proliferation of outpatient surgical facilities, a heightened emphasis on minimizing blood loss in obstetrical care, and the increasing acceptance of these technologies in emerging healthcare economies. Throughout this projected period, several significant developments are set to shape the industry landscape, such as ongoing progress in refining blood processing techniques, the incorporation of sophisticated sensing technology, tailoring equipment specifically for diverse surgical requirements, the shift towards closed-loop systems utilizing a single donor source, and the ongoing movement toward smaller, more compact device designs.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10275&type=smp

What Are The Drivers Pushing New Developments In The Autotransfusion Devices Market?

Expect the ongoing rise in cardiovascular ailments to fuel the expansion of the autotransfusion device sector. This group of conditions impacting the heart and circulatory system, known as cardiovascular diseases (CVDs), sees its impact mitigated somewhat by autotransfusion tools, which work against the reliance on blood transfusions from external donors, known as allogeneic transfusions. By facilitating the return of a patient’s own blood, these devices lower the potential for complications and adverse reactions stemming from utilizing blood provided by others. Illustratively, the American Heart Association, a US-based non-profit, noted in its 2022 Heart Disease and Stroke Statistics Update that CVDs persist as the foremost cause of mortality worldwide, responsible for an estimated 17.9 million annual fatalities. Consequently, the escalating incidence of cardiovascular diseases serves as a major impetus for the market’s forward momentum in the field of autotransfusion devices.

Which Key Segments Fueling The Autotransfusion Devices Market?

The autotransfusion devicesmarket covered in this report is segmented –

1) By Product Type: Autotransfusion Systems, Consumables And Accessories

2) By Application: Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics And Gynecology Surgeries, Other Applications

3) By End-Use: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Autotransfusion Systems: Surgical Autotransfusion Systems, Emergency Autotransfusion Systems, Continuous Flow Autotransfusion Systems

2) By Consumables And Accessories: Collection Reservoirs, Blood Filters, Tubing Sets, Pumps, Anticoagulants

What Key Innovation Trends Are Fueling Advancements In The Autotransfusion Devices Market?

Leading players within the autotransfusion apparatus sector are focused on engineering novel offerings, including advanced intelligent software designed to boost both operational effectiveness and user satisfaction. This software iteration, branded as Intelligent Control, furnishes end-users with crucial improvements intended to streamline procedures, thereby facilitating better efficiency and a superior user journey. As an illustration of this progress, Haemonetics, an American healthcare provider, secured clearance from the FDA 510(k) in March 2023 for its updated Intelligent Control software, specifically for integration with the Cell Saver Elite+ autotransfusion mechanism. This specific Cell Saver Elite+ system facilitates the reclamation of a patient’s own blood during surgical interventions where moderate to significant blood loss is anticipated, commonly seen in fields like cardiac, orthopedic, transplant, trauma, vascular, and gynecological operations. The introduction of this Intelligent Control software marks a substantial leap forward for Haemonetics’ blood salvage technology portfolio, underscoring the firm’s dedication to supplying groundbreaking remedies aimed at achieving superior patient results.

Which Major Industry Participants Are Leading The Autotransfusion Devices Market Growth?

Major companies operating in the autotransfusion devices market include Becton Dickinson And Company, Medtronic plc, LivaNova plc, Haemonetics Corporation, Fresenius SE & Co KGaA, Terumo Corporation, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, GE HealthCare Technologies Inc., Cerus Corporation, Stryker Corporation, Atrium Medical Technologies, Brightwake Ltd., Getinge AB, Beijing ZKSK Technology Co. Ltd., Braile Biomédica, Redax S.p.A., Teleflex Incorporated, Zimmer Biomet Holdings Inc., Gen World Medical Devices Corporation, Soma Technology International LLC, Beijing Jingjing Medical Equipment Co. Ltd., Johnson & Johnson Inc., Sorin Group, Baxter International Inc., Dideco, Nipro Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/autotransfusion-devices-global-market-report

What Are The Key Regional Factors Influencing The Autotransfusion Devices Market Growth?

North America was the largest region in the autotransfusion devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global autotransfusion devices market during the forecast period. The regions covered in the autotransfusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Autotransfusion Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10275&type=smp

Browse Through More Reports Similar to the Global Autotransfusion Devices Market 2025, By The Business Research Company

Carbon Footprint Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/carbon-footprint-management-global-market-report

Environmental Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/environmental-technology-global-market-report

Automatic Environmental Control Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automatic-environmental-control-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795